AUD 1.0
(-3.85%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | 3.38 Million AUD | -66.81% |
2023 | 10.2 Million AUD | 250.33% |
2022 | 2.91 Million AUD | 40.32% |
2021 | 2.07 Million AUD | 45.58% |
2020 | 1.42 Million AUD | -51.81% |
2019 | 2.95 Million AUD | 21.12% |
2018 | 2.44 Million AUD | 905.35% |
2017 | 243 Thousand AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | -460 Thousand AUD | 0.0% |
2024 FY | 3.38 Million AUD | -66.81% |
2024 Q2 | -297 Thousand AUD | 59.4% |
2024 Q1 | -731.5 Thousand AUD | -114.09% |
2024 Q3 | -460 Thousand AUD | -54.88% |
2023 Q2 | 5.01 Million AUD | 103.33% |
2023 Q1 | 2.46 Million AUD | -22.94% |
2023 FY | 10.2 Million AUD | 250.33% |
2023 Q4 | 5.19 Million AUD | 130.81% |
2023 Q3 | 2.24 Million AUD | -55.15% |
2022 Q3 | 1.3 Million AUD | -46.16% |
2022 Q2 | 2.41 Million AUD | 99.83% |
2022 Q1 | 1.21 Million AUD | 138.43% |
2022 FY | 2.91 Million AUD | 40.32% |
2022 Q4 | 3.2 Million AUD | 145.68% |
2021 Q1 | 1.25 Million AUD | 1806.82% |
2021 FY | 2.07 Million AUD | 45.58% |
2021 Q4 | -3.15 Million AUD | -130.43% |
2021 Q3 | -1.36 Million AUD | -154.31% |
2021 Q2 | 2.51 Million AUD | 100.0% |
2020 Q1 | 516 Thousand AUD | 0.0% |
2020 FY | 1.42 Million AUD | -51.81% |
2020 Q4 | 66 Thousand AUD | -69.79% |
2020 Q3 | 218.5 Thousand AUD | -78.83% |
2020 Q2 | 1.03 Million AUD | 100.0% |
2019 FY | 2.95 Million AUD | 21.12% |
2018 FY | 2.44 Million AUD | 905.35% |
2017 FY | 243 Thousand AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Austco Healthcare Limited | 6.37 Million AUD | 46.854% |
Nanosonics Limited | 9.11 Million AUD | 62.85% |
Osteopore Limited | -4.82 Million AUD | 170.256% |
SDI Limited | 20.39 Million AUD | 83.391% |